天美传媒

Dr. Borahay is the Director of Minimally Invasive Gynecologic Surgery at Johns Hopkins Bayview Medical Center. He specializes in robotic and laparoscopic surgeries for complex conditions, including uterine fibroids and advanced endometriosis. Dr. Borahay performs single-site gynecologic surgery and same-day hysterectomy.

Dr. Borahay's book Fibroids and Reproduction presents recent updates on fibroid treatment for clinicians.

Dr. Borahay is a referral expert. He has received the Center of Excellence in Minimally Invasive Gynecology designation. Notably, Dr. Borahay received the Excellence in Clinical Teaching Award from the John P. McGovern Academy of Oslerian Medicine.

Dr. Borahay is the Principal Investigator of a multi-institutional NIH-funded study of uterine fibroid that includes a clinical trial. His research focuses on developing innovative fibroid treatments. 

Dr. Borahay has authored more than 50 scientific publications. His accomplishments have been recognized at national and international conferences through more than 100 presentations.

Catherine Y. Spong, M.D., is Professor and Chair of the Department of Obstetrics and Gynecology at UT Southwestern Medical Center.
She previously served as Vice Chair for the Department and Chief of the Division of Maternal-Fetal Medicine. Dr. Spong specializes in prematurity, fetal complications, and improving outcomes in children. Her clinical responsibilities are in the Parkland Health and Hospital System.
Dr. Spong received her medical degree from the University of Missouri-Kansas City (UMKC) in 1991. After serving as Chief Resident in Obstetrics and Gynecology at the Harbor-UCLA Medical Center, she began her career at the National Institute of Child Health and Human Development (NICHD) as a Maternal-Fetal Medicine Fellow, which also included clinical work at Georgetown University. Then, she became a Clinical Associate and Senior Staff Fellow at the National Institutes of Health (NIH) and the NICHD's intramural research program. There, she directed a lab, the Unit on Perinatal and Developmental Neurobiology, that focused on neuroprotective peptides and fetal development utilizing models of fetal alcohol syndrome and Down syndrome. In 2000, she joined NICHD's extramural program.
Over a career that spanned 23 years, Dr. Spong served in many capacities at NIH, including as NICHD's Deputy Director, Acting Director, Associate Director for Extramural Research and Director of the Division of Extramural Research, and Chief of the Pregnancy and Perinatology Branch. She was the Chair of the Department of Health and Human Services (DHHS) Federal Task Force on Research Specific to Pregnant Women and Lactating Women. In 2018, she joined the faculty at UT Southwestern as Chief of the Division of Maternal-Fetal Medicine.
Among Dr. Spong's areas of expertise are maternal and child health, emphasizing prematurity, fetal complications, and improving child outcomes. One of her major research interests has been the developing fetus. She holds several patents for neuroprotective agents that help prevent fetal injury. Other research interests include improving the understanding of stillbirth, fetal surgery for myelomeningocele, zika in pregnancy, and the human placenta. During her tenure at NICHD, she launched the Human Placenta Project. She is a passionate advocate for inclusion in research for under represented groups.
Dr. Spong is board-certified in maternal-fetal medicine and obstetrics and gynecology. She is an Editor of William's Obstetrics, Management of High Risk Pregnancy, Protocols for High-Risk Pregnancies, and Stillbirth: Prediction, Prevention and Management. She has received numerous research awards, including the Society for Maternal-Fetal Medicine Achievement Award, the UMKC Alumnus of the Year Award, several NIH director's Awards, and a Surgeon General's Certificate of Appreciation for work on prematurity. She has published more than 270 peer-reviewed papers and been featured on national television and radio, including The CBS Early Show, the Diane Rehm Show, NPR's All Things Considered, CNN, and Voice of America, where she discussed women's health and pregnancy topics.

Dr. Kimia Sorouri is a clinician-researcher with an interest in fertility, particularly fertility preservation and ovarian toxicity of anti-cancer drugs and novel therapeutics. She is currently a senior resident physician in Obstetrics & Gynecology at the Lois Hole Hospital for Women, one of the highest-volume sites in Canada, and concurrently appointed as a research fellow at Dana-Farber Cancer Institute/ Harvard Medical School. 

She received her MD from the University of Toronto and her MPH from Harvard University as a Frank Knox Memorial Fellow. She then completed her postdoctoral fellowship at Dana-Farber Cancer Institute/ Harvard Medical School with Dr. Ann H. Partridge researching the reproductive health of cancer patients and survivors. In addition, she has an interest in leveraging technology to advance women’s health through her involvement with early-stage companies as an advisor and founder.